Accountable care organizations can generate medical and drug cost savings of at least 12 percent for asthma and chronic obstructive pulmonary disease patients, according to a Decision Resources report.
The findings from the U.S. Physician & Payer Forum report, "Accountable Care Organizations: How will Payer and Provider Adoption of This Model Impact Prescribing Trends in Asthma and COPD?" are based on survey results from 100 pulmonologists, 39 managed care organization pharmacy directors and two MCO medical directors.
According to the news release, the medical and drug savings from ACOs are expected to come from ACOs' focus on prescribing lower-cost therapies, patient screenings and drug adherence.
More Articles on Accountable Care Organizations:
Via Christi Health Vying for Medicare ACO
9 Pioneer ACOs Could Back Out of Program
67% of Physicians Report No Personal Financial Benefit From ACOs